Detalhe da pesquisa
1.
Bimodal expression of potential drug target CLL-1 (CLEC12A) on CD34+ blasts of AML patients.
Eur J Haematol
; 107(3): 343-353, 2021 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-34053123
2.
Durable Responses With Mosunetuzumab in Relapsed/Refractory Indolent and Aggressive B-Cell Non-Hodgkin Lymphomas: Extended Follow-Up of a Phase I/II Study.
J Clin Oncol
; : JCO2302329, 2024 Mar 28.
Artigo
Inglês
| MEDLINE | ID: mdl-38547425
3.
Measurement of conatumumab-induced apoptotic activity in tumors by fine needle aspirate sampling.
Cytometry A
; 77(9): 849-60, 2010 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-20623688